Prospective, Case-Control Study of Serological Response after Two Doses of BNT162b2 anti-SARS-CoV-2 mRNA Vaccine in Transfusion-Dependent Thalassemic Patients.

Mediterr J Hematol Infect Dis

Hematology and Bone Marrow Transplantation Unit, AOUC Policlinico, Bari, Italy.

Published: July 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266603	PMC
http://dx.doi.org/10.4084/MJHID.2022.056	DOI Listing

Publication Analysis

prospective case-control

case-control study

study serological

serological response

response doses

doses bnt162b2

bnt162b2 anti-sars-cov-2

anti-sars-cov-2 mrna

mrna vaccine

vaccine transfusion-dependent

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!